Biodexa Pharmaceuticals Income Statement (2013-2025)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2017	Jun2018	Dec2018	Jun2019	Dec2019	Jun2020	Sep2020	Dec2020	Jun2021	Sep2021	Dec2021	Jun2022	Sep2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Revenue & Cost
Revenue (Quarter)					0.00B		0.00B	0.00B			0.00B
Interest income
Interest Income - Deposits (Quarter)					0.00B		0.00B						0.00B	0.00B
Interest Income - Total (Quarter)					-0.00B		-0.00B	-0.00B						-0.00B
Interest expenses
Interest Expenses (Quarter)			-0.00B		-0.00B		-0.00B	-0.00B		-0.00B	-0.00B		-0.00B	-0.00B	-0.00B			-0.00B	-0.00B	-0.00B
Interest Income - Net (Quarter)					0.00B		-0.00B	-0.00B						-0.00B
Non-interest income
Financial Services Fees (Quarter)
Asset Management (Quarter)	0.00B
Investment Advisory (Quarter)
Trading Income (Quarter)	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B													0.00B	0.00B
Non-Interest Income (Quarter)	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B													0.00B	0.00B
Operating Items
Amortization - Intangibles (Quarter)							-0.01B	-0.02B
Research & Development (Quarter)			-0.01B		-0.01B		-0.01B	-0.01B		-0.00B	-0.00B		-0.00B	-0.00B	-0.00B			-0.00B	-0.00B
Restructuring Costs (Quarter)			-0.01B		-0.00B		-0.00B	-0.01B		-0.00B	-0.00B		-0.00B	-0.00B	-0.00B			-0.00B	-0.00B
Other Operating Expenses (Quarter)			-0.00B					0.00B		-0.00B
Operating Expenses (Quarter)			-0.02B		-0.02B		-0.01B	-0.01B		-0.01B	-0.00B		-0.01B	-0.00B	-0.01B			-0.01B	-0.01B
Operating Income (Quarter)			-0.02B		-0.01B		-0.02B	-0.03B		-0.00B	-0.00B		-0.00B	-0.00B	-0.01B			-0.01B	-0.01B
EBIT (Quarter)			-0.02B		-0.01B		-0.02B	-0.03B		-0.00B	-0.00B		-0.00B	-0.00B	-0.01B	-0.01B		-0.01B	-0.01B
Non-operating items
Interest & Investment Income (Quarter)					0.00B		0.00B	0.00B					0.00B	0.00B				0.00B
Other Non Operating Income (Quarter)			0.00B				0.00B
Net income details
EBT (Quarter)			-0.02B		-0.01B		-0.02B	-0.03B		-0.00B	-0.01B		-0.00B	-0.01B	-0.00B	-0.01B		-0.00B	-0.01B
Tax Provisions (Quarter)			0.00B		0.00B		0.00B	0.00B		0.00B	0.00B		0.00B	0.00B				0.00B
Profit After Tax (Quarter)	-0.00B		-0.01B		-0.00B		0.00B	0.00B		-0.01B	-0.00B		-0.00B	-0.01B	-0.00B	-0.01B		0.00	0.00
Income from Non-Controlling Interests (Quarter)			-0.00B		-0.00B			0.00B
Income from Continuing Operations (Quarter)			-0.02B		-0.02B		-0.02B	-0.03B		-0.01B	-0.01B		-0.00B	-0.01B	-0.00B	-0.01B		-0.00B	-0.01B
Consolidated Net Income (Quarter)	-0.01B		-0.01B		-0.00B		-0.02B	-0.03B		-0.01B	-0.01B		-0.00B	-0.01B	-0.00B	-0.01B		-0.00B	-0.01B
Income towards Parent Company (Quarter)	-0.02B		-0.01B		-0.01B		-0.02B	-0.03B		-0.00B	-0.01B		-0.00B	-0.00B	-0.00B	-0.01B		-0.00B	-0.01B
Preferred Dividend Payments (Quarter)								-0.00B			-0.00B			-0.00B		-0.00B		-0.00B
Net Income towards Common Stockholders (Quarter)	-0.02B		-0.01B		-0.01B		-0.02B	-0.03B		-0.00B	-0.01B		-0.00B	-0.00B	-0.00B	-0.01B		-0.00B	-0.01B
Additional items
EPS (Basic) (Quarter)	-193.81		-139.69		-20.51		-40.23	-21.81		-0.44	-2.92		-0.25	-1.16	0.00	0.00		0.00	0.00
EPS (Diluted) (Quarter)															0.00	0.00		0.00	0.00
Shares Outstanding (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.02B	0.02B	0.00B	4.96B	15.79B	164.04B	9.91B	5.05B	10.97B
Shares Outstanding (Diluted) (Quarter)															8.12B	8.12B	49.27B	49.27B	49.27B	49.27B
Shares Outstanding (Entity) (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B		0.00B	0.00B		0.00B	0.50B	1.58B	16.40B	0.99B	0.51B	1.10B
EBITDA (Quarter)			-0.02B		-0.01B		-0.02B	-0.03B		-0.00B	-0.00B		-0.00B	-0.00B	-0.01B	-0.01B		-0.01B	-0.01B

Research Tools

Datasets

Plans

Developers

Biodexa Pharmaceuticals BDRX Income Statement (2013-2025)

Research Tools

Datasets

Plans

Developers

Biodexa Pharmaceuticals BDRX Income Statement (2013-2025)

Create an account

Sign In

Reset Password